Personalis Inc
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
PSNL$15.88-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(64,859) | $(81,712) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Stock-based compensation expense | 8,017 | 10,662 |
| Depreciation and amortization | 8,398 | 8,389 |
| Noncash operating lease cost | 1,036 | 2,681 |
| Noncash charges related to liability classified Tempus Warrants | 18,274 | — |
| Amortization of premium (discount) on short-term investments | (1,826) | (1,400) |
| Noncash restructuring and other charges | — | 476 |
| Noncash lease impairment expense | — | 5,565 |
| Other | 56 | 214 |
| Changes in operating assets and liabilities | ||
| Accounts receivable | 4,255 | 2,976 |
| Inventory and other deferred costs | 1,979 | 201 |
| Prepaid expenses and other assets | 271 | 2,080 |
| Accounts payable | (4,135) | (749) |
| Accrued and other current liabilities | (3,161) | 1,018 |
| Contract liabilities | (3,638) | 6,216 |
| Operating lease liabilities | (2,571) | 553 |
| Other long-term liabilities | 550 | (10) |
| Net cash used in operating activities | (37,354) | (42,840) |
| Cash flows from investing activities: | ||
| Purchases of available-for-sale debt securities | (76,769) | (71,831) |
| Proceeds from maturities of available-for-sale debt securities | 68,000 | 103,955 |
| Purchases of property and equipment | (357) | (7,387) |
| Proceeds from sales of property and equipment | 240 | — |
| Net cash (used in) provided by investing activities | (8,886) | 24,737 |
| Cash flows from financing activities: | ||
| Proceeds from sales of common stock under ATM facility, net of commissions | 30,079 | 2,598 |
| Proceeds from exercise of Tempus Warrants | 18,438 | — |
| Proceeds from sale of common stock under Tempus Investment Agreement | 17,745 | — |
| Payment of costs related to Tempus Investment Agreement | (800) | — |
| Repayments of loans | (822) | (2,292) |
| Proceeds from exercise of equity awards | 431 | 909 |
| Net cash provided by financing activities | 65,071 | 1,215 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | (15) | (48) |
| Net change in cash, cash equivalents and restricted cash | 18,816 | (16,936) |
| Cash, cash equivalents and restricted cash, beginning of period | 58,774 | 90,918 |
| Cash, cash equivalents and restricted cash, end of period | $77,590 | $73,982 |
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | ||
| Cash and cash equivalents | $75,800 | $72,192 |
| Restricted cash, included in other long-term assets | 1,790 | 1,790 |
| Total cash, cash equivalents and restricted cash | $77,590 | $73,982 |
PERSONALIS, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.